Monday, October 3, 2022
Home Tags Mannkind

Tag: Mannkind

MannKind regains marketing rights to inhaled insulin

The drug went on sale in early 2015, but original and current marketer Sanofi had difficulty in marketing it effectively.

Danbury’s MannKind delivers inhalable insulin

MannKind of Danbury has developed a rapid-acting insulin inhalant called Afrezza.

MannKind will grow in Danbury

Danbury-based biotech company MannKind will grow in the city with its diabetes drug Afrezza and in two more treatment areas to be announced Monday.

Making the grade

Connecticut’s diverse manufacturing base appeared to serve it well in the recession.